Tempus AI, Inc. (TEM)
Healthcare • Health Information Services
StockNasdaqGSUnited StatesUS88023B1035
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Tempus AI, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 15:04. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 23 Feb 2027 08:00 | 0.03 | — | — | Upcoming |
| 02 Nov 2026 07:00 | -0.08 | 0.07 | +191.5% | Beat |
| 30 Jul 2026 16:00 | -0.15 | -0.04 | +74.0% | Beat |
| 05 May 2026 16:00 | -0.20 | -0.13 | +35.4% | Beat |
| 24 Feb 2026 16:00 | -0.05 | -0.04 | +22.1% | Beat |
| 04 Nov 2025 16:00 | -0.18 | -0.11 | +37.3% | Beat |
| 08 Aug 2025 06:00 | -0.25 | -0.22 | +13.0% | Beat |
| 06 May 2025 16:00 | -0.27 | -0.24 | +10.2% | Beat |
| 24 Feb 2025 16:00 | -0.15 | -0.18 | -17.5% | Miss |
| 04 Nov 2024 16:00 | -0.28 | -0.25 | +10.9% | Beat |
| 06 Aug 2024 16:00 | -1.79 | -0.63 | +64.8% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 1.3B | +83.4% | -245M | -19.3% | -1.41 | +77.4% | -245.4M |
| 2024 | 693.4M | +30.4% | -705.8M | -101.8% | -6.23 | -286.1% | -211.2M |
| 2023 | 531.8M | +65.8% | -214.1M | -40.3% | -1.61 | +22.3% | -248.9M |
| 2022 | 320.7M | — | -289.8M | -90.4% | -2.08 | — | -186.6M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| Nov 2026 In progress | 74.43 | 85.75 | 65.07 | 70.15 | -2.87% | 68,860,359 | |
| Oct 2026 | 81.98 | 87.99 | 61.51 | 72.22 | -11.82% | 141,559,500 | |
| Sep 2026 | 65.64 | 89.09 | 57.72 | 81.90 | +29.90% | 142,684,500 | |
| Aug 2026 | 43.44 | 72.96 | 42.40 | 63.05 | +43.72% | 155,351,500 | |
| Jul 2026 | 57.55 | 63.11 | 40.77 | 43.87 | -24.27% | 117,416,200 | |
| Jun 2026 | 49.51 | 59.59 | 45.31 | 57.93 | +14.78% | 156,147,100 | |
| May 2026 | 55.19 | 56.41 | 42.62 | 50.47 | -9.03% | 135,188,400 | |
| Apr 2026 | 46.15 | 58.04 | 42.41 | 55.48 | +22.69% | 112,958,300 | |
| Mar 2026 | 50.95 | 53.63 | 41.73 | 45.22 | -15.08% | 104,748,200 | |
| Feb 2026 | 59.43 | 62.00 | 49.40 | 53.25 | -10.98% | 115,991,300 | |
| 20 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Tempus to Present Six Abstracts Accepted at the 2026 Connective Tissue Oncology Society Annual Meeting (opens in a new tab) 11 Nov 2026 13:30
- The AI Debt Bill Is Coming Due, But Biotech Has Revenue to Show for the Boom (opens in a new tab) MarketBeat · 11 Nov 2026 13:10
- Tempus AI (TEM) Surged on Data Business Momentum and MRD Testing Expansion (opens in a new tab) Insider Monkey · 10 Nov 2026 17:44
- Tempus’ Partner Blood Cancer United Launches Dare To Dream REALworld: AML, Patient-Centered Initiative Co-Founded With Rally Foundation For Childhood Cancer Research (opens in a new tab) Benzinga · 10 Nov 2026 10:07
- SOTERIA Collaborates with Tempus to Advance Precision Oncology for U.S. Military and Veterans Battling Cancer (opens in a new tab) 09 Nov 2026 21:39
- SOTERIA Precision Medicine Foundation Partners With Tempus To Provide Personalized, Data-Driven Cancer Treatment Insights, Genomic Sequencing To U.S. Military (opens in a new tab) Benzinga · 09 Nov 2026 17:55
- Tempus AI: Q3 Strengthens The Platform Thesis, But Cash Returns Still Need To Catch Up (opens in a new tab) SeekingAlpha · 07 Nov 2026 21:48
- Tempus AI: An Inflection Point Has Arrived (Earnings Analysis) (opens in a new tab) SeekingAlpha · 04 Nov 2026 05:49
- Jefferies Upgrades Tempus AI to Hold, Raises Price Target to $70 (opens in a new tab) Benzinga · 03 Nov 2026 16:13
- Freedom Capital Markets Maintains Hold on Tempus AI, Raises Price Target to $89 (opens in a new tab) Benzinga · 03 Nov 2026 15:41
- TEM Q3 Earnings Call Highlights Growth and 2027 Pricing Upside (opens in a new tab) Zacks · 03 Nov 2026 14:00
- Why Tempus AI Stock Is Up 8.7% And What's Next (opens in a new tab) Simply Wall St. · 03 Nov 2026 12:09
- Tempus AI (TEM) Stock Looks Fully Priced Following Its 26% Run (opens in a new tab) Simply Wall St. · 03 Nov 2026 11:07
- HC Wainwright & Co. Maintains Buy on Tempus AI, Raises Price Target to $85 (opens in a new tab) Benzinga · 03 Nov 2026 08:20
- Tempus AI Analysts Boost Their Forecasts Following Strong Q3 Results (opens in a new tab) Benzinga · 03 Nov 2026 08:02
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 75.89 USD
- Market cap
- 13.8B
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Health Information Services
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow TEM and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.